Changeflow GovPing Healthcare & Life Sciences Amgen Granted Design Patent for Handheld Drug D...
Routine Notice Added Final

Amgen Granted Design Patent for Handheld Drug Delivery Device

Favicon for changeflow.com USPTO Patent Grants - Medical Devices (A61M)
Published
Detected
Email

Summary

Amgen Inc. has been granted US Design Patent USD1123151S1 for a handheld drug delivery device. The patent has 1 claim and covers a design for a drug delivery device classified under CPC codes A61M 5/3156, A61M 5/31591, A61M 5/3155, A61M 5/3157, A61M 5/24, A61M 5/31501, A61M 5/31551, and A61M 5/31585. The application was filed on January 7, 2025, with Application No. 29982678, and the patent issued on April 21, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 48 changes logged to date.

What changed

USPTO granted Design Patent USD1123151S1 to Amgen Inc. for a handheld drug delivery device design. The patent has 1 claim and covers multiple CPC classifications related to syringes, injection pens, and drug delivery mechanisms.

The grant of this design patent gives Amgen Inc. intellectual property protection for the ornamental design of the handheld drug delivery device. Competitors in the drug delivery device space should be aware that this design is now protected, though design patents protect only the ornamental appearance rather than functional aspects.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Handheld drug delivery device

Design USD1123151S1 Kind: S1 Apr 21, 2026

Assignee

AMGEN INC.

Inventors

Austin Davis, Lars Eilertsen, David Lavmand Muller, Rasmus Ohlenschlaeger, Gregory Thomas Nowak, Kasper Poder, Dylan Bourelle

CPC Classifications

A61M 5/3156 A61M 5/31591 A61M 5/3155 A61M 5/3157 A61M 5/24 A61M 5/31501 A61M 5/31551 A61M 5/31585

Filing Date

2025-01-07

Application No.

29982678

Claims

1

View original document →

Parties

Get daily alerts for USPTO Patent Grants - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Design patent grants Drug delivery devices Intellectual property
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!